Aquestive Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03843E1047

SecurityAQST / Aquestive Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership565,203 shares
Latest Disclosed Value $ 2,345,592
Citadel Advisors Llc ownership in AQST / Aquestive Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 565,203 shares of Aquestive Therapeutics, Inc. (US:AQST) valued at $2,345,592 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 570,945 shares of Aquestive Therapeutics, Inc.. This represents a change in shares of -1.01% during the quarter. The current value of the position is $2,221,248 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AQST) in the form of stock options. The firm currently holds call options representing 328,200 of underlying shares valued at $1,362,030 USD and put options representing 126,100 of underlying shares valued at $523,315 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AQST / Aquestive Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 565,203 -5,742 -1.01 2,346 -36.42 0.0003
2026-02-17 2025-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 570,945 -197,505 -25.70 3,688 -14.13 0.0005
2025-11-14 2025-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 768,450 616,294 405.04 4,296 753.88 0.0007
2025-08-14 2025-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 152,156 -307,394 -66.89 504 -62.24 0.0001
2025-05-15 2025-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 459,550 77,872 20.40 1,333 -1.91 0.0003
2025-02-14 2024-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 381,678 -490,155 -56.22 1,359 -68.72 0.0002
2024-11-14 2024-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 871,833 704,020 419.53 4,342 895.64 0.0008
2024-08-14 2024-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 167,813 -56,460 -25.17 436 -54.35 0.0001
2024-05-15 2024-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 224,273 56,456 33.64 955 182.54 0.0002
2024-02-14 2023-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 167,817 165,112 6,103.96 339 8,350.00 0.0001
2023-11-14 2023-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 2,705 -582 -17.71 4 -20.00 0.0000
2023-08-14 2023-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 3,287 3,287 5 0.0000
2023-05-15 2023-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 0 -2,910 -100.00 0 -100.00
2023-02-14 2022-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 2,910 -15,153 -83.89 3 -90.48 0.0000
2022-11-14 2022-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 18,063 -53,932 -74.91 21 -54.35 0.0000
2022-08-15 2022-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 71,995 35,205 95.69 46 -52.08 0.0000
2022-05-16 2022-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 36,790 -61,078 -62.41 96 -74.80 0.0000
2022-02-14 2021-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 97,868 56,157 134.63 381 109.34 0.0001
2021-11-15 2021-09-30 13F AQUESTIVE THERAPEUTICS Cmn 03843E104 41,711 41,711 182 0.0000
2021-08-16 2021-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 0 -75,463 -100.00 0 -100.00
2021-05-21 2021-03-31 13F/A-1 AQUESTIVE THERAPEUTICS COM 03843E104 75,463 51,209 211.14 392 201.54 0.0001
2021-05-17 2021-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 75,463 51,209 392 0.0001
2021-02-16 2020-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 24,254 -31,738 -56.68 130 -52.21 0.0000
2020-11-16 2020-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 55,992 29,765 113.49 272 114.17 0.0001
2020-08-14 2020-06-30 13F AQUESTIVE THERAPEUTICS Cmn 03843E104 26,227 15,605 146.91 127 452.17 0.0000
2020-05-15 2020-03-31 13F AQUESTIVE THERAPEUTICS Cmn 03843E104 10,622 10,622 23 0.0000
2019-02-14 2018-12-31 13F AQUESTIVE THERAPEUTICS Cmn 03843E104 0 -25,780 -100.00 0 -100.00
2018-11-13 2018-09-30 13F AQUESTIVE THERAPEUTICS Cmn 03843E104 25,780 25,780 451 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AQUESTIVE THERAPEUTICS COM Call 328,200 33.52 1,362 -14.18 n/a n/a n/a
2026-02-17 2025-12-31 13F AQUESTIVE THERAPEUTICS COM Call 245,800 282.87 1,588 343.30 n/a n/a n/a
2025-11-14 2025-09-30 13F AQUESTIVE THERAPEUTICS COM Call 64,200 316.88 359 616.00 n/a n/a n/a
2025-08-14 2025-06-30 13F AQUESTIVE THERAPEUTICS COM Call 15,400 3,750.00 51 4,900.00 n/a n/a n/a
2025-05-15 2025-03-31 13F AQUESTIVE THERAPEUTICS COM Call 400 -97.75 1 -98.41 n/a n/a n/a
2025-02-14 2024-12-31 13F AQUESTIVE THERAPEUTICS COM Call 17,800 -76.30 63 -83.11 n/a n/a n/a
2024-11-14 2024-09-30 13F AQUESTIVE THERAPEUTICS COM Call 75,100 22.31 374 134.59 n/a n/a n/a
2024-08-14 2024-06-30 13F AQUESTIVE THERAPEUTICS COM Call 61,400 83.28 160 11.97 n/a n/a n/a
2024-05-15 2024-03-31 13F AQUESTIVE THERAPEUTICS COM Call 33,500 104.27 143 330.30 n/a n/a n/a
2024-02-14 2023-12-31 13F AQUESTIVE THERAPEUTICS COM Call 16,400 -12.30 33 17.86 n/a n/a n/a
2023-11-14 2023-09-30 13F AQUESTIVE THERAPEUTICS COM Call 18,700 120.00 29 100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F AQUESTIVE THERAPEUTICS COM Call 8,500 -51.70 14 -30.00 n/a n/a n/a
2023-05-15 2023-03-31 13F AQUESTIVE THERAPEUTICS COM Call 17,600 -64.94 20 -55.56 n/a n/a n/a
2023-02-14 2022-12-31 13F AQUESTIVE THERAPEUTICS COM Call 50,200 45 n/a n/a n/a
2022-11-14 2022-09-30 13F AQUESTIVE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F AQUESTIVE THERAPEUTICS COM Call 51,300 266.43 33 -10.81 n/a n/a n/a
2022-05-16 2022-03-31 13F AQUESTIVE THERAPEUTICS COM Call 14,000 -74.55 37 -82.71 n/a n/a n/a
2022-02-14 2021-12-31 13F AQUESTIVE THERAPEUTICS COM Call 55,000 -28.29 214 -35.93 n/a n/a n/a
2021-11-15 2021-09-30 13F AQUESTIVE THERAPEUTICS Cmn Call 76,700 32.70 334 45.85 n/a n/a n/a
2021-08-16 2021-06-30 13F AQUESTIVE THERAPEUTICS COM Call 57,800 37.95 229 5.05 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AQUESTIVE THERAPEUTICS COM Call 41,900 193.01 218 183.12 n/a n/a n/a
2021-05-17 2021-03-31 13F AQUESTIVE THERAPEUTICS COM Call 41,900 218 n/a n/a n/a
2021-02-16 2020-12-31 13F AQUESTIVE THERAPEUTICS COM Call 14,300 -43.92 77 -37.90 n/a n/a n/a
2020-11-16 2020-09-30 13F AQUESTIVE THERAPEUTICS COM Call 25,500 145.19 124 143.14 n/a n/a n/a
2020-08-14 2020-06-30 13F AQUESTIVE THERAPEUTICS Cmn Call 10,400 51 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AQUESTIVE THERAPEUTICS COM Put 126,100 -8.22 523 -41.04 n/a n/a n/a
2026-02-17 2025-12-31 13F AQUESTIVE THERAPEUTICS COM Put 137,400 -32.75 888 -22.33 n/a n/a n/a
2025-11-14 2025-09-30 13F AQUESTIVE THERAPEUTICS COM Put 204,300 79.68 1,142 203.72 n/a n/a n/a
2025-08-14 2025-06-30 13F AQUESTIVE THERAPEUTICS COM Put 113,700 -16.76 376 -5.05 n/a n/a n/a
2025-05-15 2025-03-31 13F AQUESTIVE THERAPEUTICS COM Put 136,600 108.55 396 69.96 n/a n/a n/a
2025-02-14 2024-12-31 13F AQUESTIVE THERAPEUTICS COM Put 65,500 8.99 233 -22.07 n/a n/a n/a
2024-11-14 2024-09-30 13F AQUESTIVE THERAPEUTICS COM Put 60,100 10.89 299 113.57 n/a n/a n/a
2024-08-14 2024-06-30 13F AQUESTIVE THERAPEUTICS COM Put 54,200 -49.77 141 -69.50 n/a n/a n/a
2024-05-15 2024-03-31 13F AQUESTIVE THERAPEUTICS COM Put 107,900 53,850.00 460 n/a n/a n/a
2024-02-14 2023-12-31 13F AQUESTIVE THERAPEUTICS COM Put 200 -85.71 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F AQUESTIVE THERAPEUTICS COM Put 1,400 75.00 2 100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F AQUESTIVE THERAPEUTICS COM Put 800 166.67 1 n/a n/a n/a
2023-05-15 2023-03-31 13F AQUESTIVE THERAPEUTICS COM Put 300 -62.50 0 n/a n/a n/a
2023-02-14 2022-12-31 13F AQUESTIVE THERAPEUTICS COM Put 800 1 n/a n/a n/a
2022-08-15 2022-06-30 13F AQUESTIVE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F AQUESTIVE THERAPEUTICS COM Put 11,900 -79.80 31 -86.46 n/a n/a n/a
2022-02-14 2021-12-31 13F AQUESTIVE THERAPEUTICS COM Put 58,900 82.92 229 63.57 n/a n/a n/a
2021-11-15 2021-09-30 13F AQUESTIVE THERAPEUTICS Cmn Put 32,200 88.30 140 105.88 n/a n/a n/a
2021-08-16 2021-06-30 13F AQUESTIVE THERAPEUTICS COM Put 17,100 -71.59 68 -78.27 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AQUESTIVE THERAPEUTICS COM Put 60,200 -39.68 313 -41.39 n/a n/a n/a
2021-05-17 2021-03-31 13F AQUESTIVE THERAPEUTICS COM Put 60,200 313 n/a n/a n/a
2021-02-16 2020-12-31 13F AQUESTIVE THERAPEUTICS COM Put 99,800 107.48 534 128.21 n/a n/a n/a
2020-11-16 2020-09-30 13F AQUESTIVE THERAPEUTICS COM Put 48,100 68.77 234 68.35 n/a n/a n/a
2020-08-14 2020-06-30 13F AQUESTIVE THERAPEUTICS Cmn Put 28,500 139 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.